Retension Pharmaceuticals

Private

Falls Church, VirginiaHealthcare & Life Scienceshttps://www.retensionpharmaceuticals.com/

Last Round

Series B

Aug 6, 2025

Total Funding Raised

$25.4M

Company Overview

Retension Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for the treatment of hypertension and other serious cardiovascular conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalresistant hypertensionPDE5 inhibitorclinical trialscardiovascular therapeuticssmall molecule drugdrug developmenthypertension treatmentbiotechclinical-stage pharmauncontrolled hypertensionnitric oxide signalingdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Retension Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Retension Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Retension Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Aug 6, 2025
Series A	Aug 21, 2024

View all Funding Rounds

Retension Pharmaceuticals Investors

Notable investors and investment history

Retension Pharmaceuticals investors
Investor	Rounds
Dais Partners	Series B
Collage Venture Partners	Series A, Series B
Transhuman Capital	Series B
Green Park & Golf Ventures	Series B

View all Investors

Retension Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Retension Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Retension Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersFalls Church, Virginia

Employee Range13

Year Founded2023

Last FundingAug 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.